IMCYSE IMOTOPE

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark IMCYSE IMOTOPE was filed as Word mark on 12/21/2020 at the World Intellectual Property Organization.

Trademark Details Last update: July 27, 2022

Trademark form Word mark
File reference 1581291
Register number 1424344
Countries Canada
Base trademark BX No. 1424344, December 16, 2020
Application date December 21, 2020
Expiration date December 21, 2030

Trademark owner

Avenue de l'hôpital 1,
Tour GIGA (B34)
BE

Trademark representatives

Holidaystraat 5 B-1831 Diegem BE

goods and services

05 Pharmaceutical products, namely, pharmaceutical products for treatment and prevention of autoimmune diseases, infectious diseases, cancer, multiple sclerosis, type-1 diabetes, myasthenia gravis, rheumatoid arthritis and viral diseases, allergies, celiac disease and immune responses against allofactors used in therapy or against viral vectors used in gene therapy or gene vaccination and autoimmune responses to organ and cell transplantation; veterinary preparations for mammals used in treatment and prevention of autoimmune diseases, infectious diseases and cancer; vaccines for humans; vaccine preparations for human or veterinary use
42 Scientific and technological services as well as research and design services relating thereto, namely, scientific research, analysis and design in the fields of immunology, chronic diseases, infectious diseases, cancer and damaged organ regeneration; industrial analysis and research services, namely, in the field of immunology, chronic diseases, infectious diseases, cancer and damaged organ regeneration; research and development services relating to vaccines and medicines

Trademark history

Date Document number Area Entry
July 11, 2022 2022/28 Gaz CA Rejection
December 21, 2020 2021/9 Gaz BX Registration

ID: 141581291